CD8 T cell mediated disruption of Blood Brain Barrier Tight Junctions
CD8 T 细胞介导的血脑屏障紧密连接破坏
基本信息
- 批准号:9392836
- 负责人:
- 金额:$ 34.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-01 至 2020-06-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS Dementia ComplexAcuteAcute Hemorrhagic LeukoencephalitisAlzheimer&aposs DiseaseAntigensAreaBiological ModelsBlood - brain barrier anatomyBlood VesselsBrainC57BL/6 MouseCD8-Positive T-LymphocytesCD8B1 geneCellsCerebral MalariaChemicalsConfocal MicroscopyCre-LoxPCritical PathwaysDataDiseaseDisease modelE proteinEpilepsyExperimental ModelsFlow CytometryGlioblastomaGoalsHIVHumanImmuneImmunohistochemistryImmunological ModelsInflammationInflammatoryInvestigationKDR geneLaboratoriesMagnetic Resonance ImagingMammalsMediatingModelingMonitorMultiple SclerosisMusNeuronsNeuropilin-1PathologyPeptidesPermeabilityPlasmodium bergheiPlayProcessProtein BiochemistryResearchResolutionRoleSignal TransductionSolidStrokeSyndromeTMEVTestingTherapeuticTherapeutic InterventionTight JunctionsTransgenic MiceTraumatic Brain InjuryUp-RegulationVariantVascular Endothelial CellVascular Endothelial Growth FactorsVascular PermeabilitiesViral AntigensViral Hemorrhagic FeversWorkanimal model developmentbasebehavioral studybrain endothelial cellcell typecytokinein vivoin vivo imaginginnovationinsightintravital imagingintravital microscopymouse modelnervous system disorderneuroinflammationneurovascular unitnovelperforinprogramsreceptortwo-photonvascular contributions
项目摘要
Abstract
Blood brain barrier (BBB) disruption is an integral feature of neurological diseases as diverse as
multiple sclerosis, acute hemorrhagic leukoencephalitis (AHLE), traumatic brain injury, stroke,
cerebral malaria, viral hemorrhagic fevers, epilepsy, glioblastoma, alzheimer's disease, and HIV
dementia. A fundamental question in these diseases is the extent inflammatory immune cells
contribute to CNS vascular permeability. This lack of understanding currently undermines
therapeutic approaches to treat neurological disease in which uncontrolled BBB disruption
contributes to pathology. My research program was the first to demonstrate that CD8 T cells
have the capacity to disrupt BBB tight junctions using a novel murine model. Using this model,
we have developed a tractable approach to dissect immune-mediated mechanisms of vascular
endothelial growth factor (VEGF) mediated BBB disruption using a variation of Theiler's Murine
Encephalomyelitis Virus (TMEV) and the Plasmodium berghei ANKA (PbA) model systems.
Our central hypothesis is CD8 T cells promote neuronal expression of VEGF which
results in disruption of cerebral endothelial cell tight junctions and vascular permeability.
We will test our central hypothesis through the following aims:
Specific Aim #1 – Determine the extent direct engagement of antigen specific CD8 T cells with
neurons promotes VEGF expression and ensuing vascular changes.
Specific Aim #2 – Determine the extent neuronal expression of VEGF and its receptors
contribute to CD8 T cell-initiated BBB disruption.
Specific Aim #3 – Evaluate the contribution of neuronal VEGF to CD8 T cell-mediated BBB
disruption in the Plasmodium berghei ANKA (PbA) model of experimental cerebral malaria.
To our knowledge, no other laboratories have a similar mouse as PIFS that capitalizes on
readily inducible acute CNS vascular permeability mediated by a well-defined immune cell type.
Confirming the existence of homologous inflammatory mechanisms in humans would be the first
step toward therapeutic intervention of neurological diseases in which neuroinflammation
induced CNS vascular permeability plays a significant part. To accomplish these aims, we will
employ: (a) flow cytometry, (b) behavioral studies, (c) high resolution confocal microscopy and
immunohistochemistry, (d) 2-photon intravital microscopy (e) protein biochemistry, and (f) small
mammal MRI.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Aaron J Johnson其他文献
Use of a static progressive stretch orthosis to treat post-traumatic ankle stiffness
- DOI:
10.1186/1756-0500-5-348 - 发表时间:
2012-07-04 - 期刊:
- 影响因子:1.700
- 作者:
Christopher R Costa;Mark J McElroy;Aaron J Johnson;Bradley M Lamm;Michael A Mont - 通讯作者:
Michael A Mont
Are component positioning and prosthesis size associated with hip resurfacing failure?
- DOI:
10.1186/1471-2474-11-227 - 发表时间:
2010-10-02 - 期刊:
- 影响因子:2.400
- 作者:
David R Marker;Michael G Zywiel;Aaron J Johnson;Thorsten M Seyler;Michael A Mont - 通讯作者:
Michael A Mont
Aaron J Johnson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Aaron J Johnson', 18)}}的其他基金
Defining MHC class I restricted antigen presentation to CD8 T cells in experimental AD and Tauopathy - Supplement
定义实验性 AD 和 Tau 病中 MHC I 类限制性抗原呈递至 CD8 T 细胞 - 补充
- 批准号:
10836880 - 财政年份:2023
- 资助金额:
$ 34.78万 - 项目类别:
Defining MHC class I restricted antigen presentation to CD8 T cells in experimental AD and Tauopathy
定义实验性 AD 和 Tau 病中 MHC I 类限制性抗原呈递至 CD8 T 细胞
- 批准号:
10229223 - 财政年份:2021
- 资助金额:
$ 34.78万 - 项目类别:
CD8 T cell mediated disruption of Blood Brain Barrier Tight Junctions
CD8 T 细胞介导的血脑屏障紧密连接破坏
- 批准号:
10609855 - 财政年份:2017
- 资助金额:
$ 34.78万 - 项目类别:
CD8 T cell mediated disruption of Blood Brain Barrier Tight Junctions
CD8 T 细胞介导的血脑屏障紧密连接破坏
- 批准号:
10199061 - 财政年份:2017
- 资助金额:
$ 34.78万 - 项目类别:
CD8 T cell mediated disruption of Blood Brain Barrier Tight Junctions
CD8 T 细胞介导的血脑屏障紧密连接破坏
- 批准号:
10391533 - 财政年份:2017
- 资助金额:
$ 34.78万 - 项目类别:
CD8 T cell mediated disruption of Blood Brain Barrier Tight Junctions
CD8 T 细胞介导的血脑屏障紧密连接破坏
- 批准号:
9293869 - 财政年份:2016
- 资助金额:
$ 34.78万 - 项目类别:
CD 8 T Cell Mediated Disruption of Blood Brain Tight Junction
CD 8 T 细胞介导的血脑紧密连接破坏
- 批准号:
8306282 - 财政年份:2009
- 资助金额:
$ 34.78万 - 项目类别:
CD 8 T Cell Mediated Disruption of Blood Brain Tight Junction
CD 8 T 细胞介导的血脑紧密连接破坏
- 批准号:
8509031 - 财政年份:2009
- 资助金额:
$ 34.78万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 34.78万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 34.78万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 34.78万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 34.78万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 34.78万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 34.78万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 34.78万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 34.78万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 34.78万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 34.78万 - 项目类别:
Operating Grants














{{item.name}}会员




